Literature DB >> 10448742

Optic nerve head morphologic characteristics in high-tension and normal-tension glaucoma.

M Iester1, F S Mikelberg.   

Abstract

OBJECTIVES: To determine the morphometric parameters in high-tension glaucoma (HTG) and normal-tension glaucoma (NTG) with a confocal scanning laser ophthalmoscope, and to determine the relationship to disc size.
METHODS: One hundred eighty-six patients with glaucoma were recruited for this study. For each patient, only one eye was randomly chosen. Patients with NTG and HTG were classified using untreated intraocular pressure (IOP) as the variable; the NTG group had IOP less than 22 mm Hg during a diurnal tension curve, while patients with HTG had IOP greater than 21 mm Hg in at least 3 measurements. All the patients were examined with Humphrey perimeter program 30-2 and a Heidelberg Retina Tomograph. Findings were assessed by t test. Patients were then divided by disc area size into 3 subgroups: small discs with an area less than 2 mm2, midsized discs with an area of 2 to 3 mm2, and large discs with an area greater than 3 mm2.
RESULTS: One hundred thirty-two HTG eyes and 50 NTG eyes were assessed. Four eyes were excluded because they were classified as having secondary glaucoma. No significant differences were found between HTG and NTG eyes for any Heidelberg Retina Tomograph morphometric parameters, even when patients were divided into subgroups.
CONCLUSION: No differences were apparent between HTG and NTG in morphometric parameters as measured by scanning laser ophthalmoscopy.

Entities:  

Mesh:

Year:  1999        PMID: 10448742     DOI: 10.1001/archopht.117.8.1010

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

1.  Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma.

Authors:  Ciro Costagliola; Francesco Parmeggiani; Gianni Virgili; Giuseppe Lamberti; Carlo Incorvaia; Paolo Perri; Claudio Campa; Adolfo Sebastiani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-11-15       Impact factor: 3.117

2.  Normal versus high tension glaucoma: a comparison of functional and structural defects.

Authors:  Oraorn Thonginnetra; Vivienne C Greenstein; David Chu; Jeffrey M Liebmann; Robert Ritch; Donald C Hood
Journal:  J Glaucoma       Date:  2010-03       Impact factor: 2.503

3.  Structure-function relationship between Bruch's membrane opening-minimum rim width and perimetry in open-angle glaucoma subtypes.

Authors:  Ruoshi Li; Xia Wang; Yahui Wei; Yuan Fang; Tian Tian; Mei Li; Yu Cai; Yingzi Pan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-10       Impact factor: 3.117

4.  Acute orbital effects of retrobulbar injection on optic nerve head topography.

Authors:  Y Akar; K C Apaydin; A Ozel
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

Review 5.  Optic disk size and glaucoma.

Authors:  Esther M Hoffmann; Linda M Zangwill; Jonathan G Crowston; Robert N Weinreb
Journal:  Surv Ophthalmol       Date:  2007 Jan-Feb       Impact factor: 6.197

6.  Comparison of retinal nerve fiber layer measurements between NTG and HTG using GDx-vCC.

Authors:  J I Yong Jung; Jae-hyung Kim; Michael S Kook
Journal:  Korean J Ophthalmol       Date:  2006-03

7.  Visual field loss morphology in high- and normal-tension glaucoma.

Authors:  Michele Iester; Fabio De Feo; Gordon R Douglas
Journal:  J Ophthalmol       Date:  2012-02-08       Impact factor: 1.909

8.  Incidence of glaucomatous visual field loss after two decades of follow-up: the Rotterdam Study.

Authors:  Henriët Springelkamp; Roger C Wolfs; Wishal D Ramdas; Albert Hofman; Johannes R Vingerling; Caroline C Klaver; Nomdo M Jansonius
Journal:  Eur J Epidemiol       Date:  2017-06-12       Impact factor: 8.082

9.  Hemisphere opposite to vascular trunk deviation is earlier affected by glaucomatous damage in myopic high-tension glaucoma.

Authors:  Kyoung Min Lee; Martha Kim; Sohee Oh; Seok Hwan Kim
Journal:  PLoS One       Date:  2020-05-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.